CAH Form 4: CEO Hollar reports 245,420 performance share units to settle Aug 15, 2025

Rhea-AI Filing Summary

Jason M. Hollar, identified as Chief Executive Officer, filed a Form 4 for Cardinal Health, Inc. (CAH) reporting a transaction dated 08/12/2025. The filing shows an acquisition of 245,420 common shares recorded as performance share units that the filer states will settle on August 15, 2025. The reported price is $0 and the filing lists 437,235 shares beneficially owned following the reported transaction. The form is signed by James E. Barnett, Attorney-in-fact on 08/12/2025.

Positive

• Reporting person identified: Jason M. Hollar is listed as Chief Executive Officer of Cardinal Health.
• Transaction details disclosed: Acquisition of 245,420 common shares (performance share units) with settlement on August 15, 2025, and 437,235 shares beneficially owned after the transaction.

Negative

• None.

Insights

Securities Analyst

TL;DR: CEO Jason Hollar reported receipt of 245,420 performance-based common shares, increasing reported beneficial ownership to 437,235 shares.

The Form 4 shows a non-cash acquisition of 245,420 common shares recorded as performance share units that will settle on August 15, 2025. The transaction date and the filing date are both 08/12/2025, and the reported price is $0, consistent with equity grants rather than open-market purchases. Beneficial ownership following the transaction is reported as 437,235 shares. From a securities perspective, this is a routine insider equity award disclosure rather than an open-market trading signal.

Corporate Governance Expert

TL;DR: The CEO disclosed a grant-settling award; the filing documents grant terms and resulting beneficial ownership but contains no unusual governance actions.

The filing identifies the reporting person as the company CEO and documents a grant-style transaction described as performance share units to be settled on August 15, 2025. The Form 4 includes the standard explanatory remark and a signature by an attorney-in-fact. There is no amendment indicated and no derivative transactions reported. This disclosure fulfills Section 16 reporting obligations for an equity award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hollar Jason M.

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OH 43017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/12/2025		A(1)		245,420	A	$0	437,235	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects performance share units that will settle on August 15, 2025.

Remarks:

	/s/ James E. Barnett, Attorney-in-fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Cardinal Health (CAH)?

The Form 4 was filed by Jason M. Hollar, identified as Chief Executive Officer.

What transaction is reported on the Form 4 dated 08/12/2025?

The filing reports an acquisition of 245,420 common shares recorded as performance share units.

When will the performance share units settle?

The filer states the performance share units will settle on August 15, 2025.

What is the reported beneficial ownership after the transaction?

The Form 4 lists 437,235 shares beneficially owned following the reported transaction.

What price is reported for the acquisition?

The reported price for the transaction is listed as $0.